Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up

Documenti analoghi

• Antibiotic Resistance in Helicobacter pylori in the Asia‐Pacific Region: A Call for Coordinated Regional Strategies
  di: Koji Otani, et al.
  Pubblicazione: (2025)
• Body mass index of 23 or greater is relevant to hepatic steatosis and fibrosis in patients with harmful alcohol use
  di: Keisuke Kakisaka, et al.
  Pubblicazione: (2024)
• Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
  di: Tyng‐Yuan Jang, et al.
  Pubblicazione: (2025)
• A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging‐derived proton density fat fraction
  di: Sadanobu Ogawa, et al.
  Pubblicazione: (2024)
• Medical Costs Increase Over Time for Primary Biliary Cholangitis Patients: A 20‐Year Population‐Based Study
  di: Jur‐Shan Cheng, et al.
  Pubblicazione: (2026)